Difference between revisions of "ICRP Glossary"
Line 118: | Line 118: | ||
[[Categories of exposure]] | [[Categories of exposure]] | ||
+ | |||
+ | [[Category of exposed individual]] | ||
+ | |||
+ | [[Cell death]] | ||
+ | |||
+ | [[Chromosome dosimetry]] | ||
+ | |||
+ | [[Chronic exposure]] | ||
+ | |||
+ | [[Class SR-0 gases]] | ||
+ | |||
+ | [[Class SR-1 gases]] | ||
+ | |||
+ | [[Class SR-2 gases]] | ||
+ | |||
+ | [[Clearance level]] | ||
+ | |||
+ | [[Clonogenic cells]] | ||
+ | |||
+ | [[Clonogenic survival]] | ||
[[Co-expertise]] | [[Co-expertise]] | ||
+ | |||
+ | [[Colony]] | ||
+ | |||
+ | [[Committed effective dose, E(τ)]] | ||
+ | |||
+ | [[Commodity]] | ||
+ | |||
+ | [[Complex tissues]] | ||
+ | |||
+ | [[Computed tomography dose index, CTDI]] | ||
+ | |||
+ | [[Conditional renewing (complex or flexible) tissues]] | ||
+ | |||
+ | [[Confidence limits]] | ||
+ | |||
+ | [[Confinement]] | ||
+ | |||
+ | [[Connective tissue]] | ||
+ | |||
+ | [[Consequential late effects]] | ||
+ | |||
+ | [[Constancy test]] | ||
+ | |||
+ | [[Consumer product]] | ||
[[Contamination]] | [[Contamination]] | ||
+ | |||
+ | [[Control measures]] | ||
+ | |||
+ | [[Coronary heart disease/congestive heart disease]] | ||
+ | |||
+ | [[Cortical (bone) marrow]] | ||
+ | |||
+ | [[Cost-benefit analysis]] | ||
+ | |||
+ | [[Coster-Kronig (CK) transition]] | ||
+ | |||
+ | [[Critical group]] | ||
+ | |||
+ | [[Curie, Ci]] | ||
+ | |||
+ | [[Cytokines]] | ||
+ | |||
+ | [[D0]] | ||
+ | |||
+ | [[Decay constant]] | ||
+ | |||
+ | [[Decision threshold]] | ||
+ | |||
+ | [[Decommissioning]] | ||
[[Decontamination]] | [[Decontamination]] | ||
+ | |||
+ | [[Decontamination factor]] | ||
+ | |||
+ | [[Defence-in-depth]] | ||
[[Deontological Ethics]] | [[Deontological Ethics]] | ||
+ | |||
+ | [[Deposition class]] | ||
+ | |||
+ | [[Derived consideration reference level]] | ||
+ | |||
+ | [[Diastasis]] | ||
+ | |||
+ | [[Dichotomous]] | ||
+ | |||
+ | [[Differentiation]] | ||
[[Dignity]] | [[Dignity]] | ||
+ | |||
+ | [[Direct bioassay]] | ||
+ | |||
+ | [[Disposal]] | ||
+ | |||
+ | [[Disposal Facility]] | ||
+ | |||
+ | [[DNA damage signalling]] | ||
+ | |||
+ | [[Dose assessment/estimation]] | ||
[[Dose constraint]] | [[Dose constraint]] | ||
[[Dose criteria]] | [[Dose criteria]] | ||
+ | |||
+ | [[Dose equivalent in an organ or tissue, HT,Q]] | ||
[[Dose limit]] | [[Dose limit]] | ||
+ | |||
+ | [[Dose Modifying Factor (DMF)]] | ||
+ | |||
+ | [[Dose per unit intake, DPUI]] | ||
+ | |||
+ | [[Dose rate]] | ||
+ | |||
+ | [[Dose rate effectiveness factor, DREF]] | ||
+ | |||
+ | [[Dosemeter/dosimeter]] | ||
+ | |||
+ | [[Dose-rate effect]] | ||
+ | |||
+ | [[Dose–response function (DRF)]] | ||
+ | |||
+ | [[Dose-threshold]] | ||
+ | |||
+ | [[Dosimetrists]] | ||
+ | |||
+ | [[Dysrhythmia]] | ||
+ | |||
+ | [[Early effect]] | ||
+ | |||
+ | [[Early normal tissue responses]] | ||
+ | |||
+ | [[Effect Dose 50 (ED50)]] | ||
+ | |||
+ | [[Effective charge number, Z*]] | ||
+ | |||
+ | [[Effective dose equivalent, HE]] | ||
+ | |||
+ | [[Effective half-life (Teff)]] | ||
+ | |||
+ | [[Electron-capture decay]] | ||
+ | |||
+ | [[Electrophysiology]] | ||
+ | |||
+ | [[Emergency]] | ||
[[Emergency exposure situation]] | [[Emergency exposure situation]] | ||
+ | |||
+ | [[Emergency plan]] | ||
+ | |||
+ | [[Emergency preparedness]] | ||
+ | |||
+ | [[Emergency procedures]] | ||
+ | |||
+ | [[Emergency Worker]] | ||
+ | |||
+ | [[Endogeneous excretion]] | ||
+ | |||
+ | [[Entrance surface dose]] | ||
+ | |||
+ | [[Environmental (radiation) monitoring]] | ||
[[Environmental exposure]] | [[Environmental exposure]] | ||
+ | |||
+ | [[Environmental radiation protection]] | ||
+ | |||
+ | [[Epithelium]] | ||
[[Equity]] | [[Equity]] | ||
+ | |||
+ | [[Equivalent dose (HT)]] | ||
+ | |||
+ | [[Erythropoietin]] | ||
[[Ethics]] | [[Ethics]] | ||
+ | |||
+ | [[Event tree analysis]] | ||
+ | |||
+ | [[Excretion function]] | ||
+ | |||
+ | [[Excretion rate]] | ||
+ | |||
+ | [[Exempt waste]] | ||
+ | |||
+ | [[Exemption level]] | ||
[[Existing exposure situation]] | [[Existing exposure situation]] | ||
+ | |||
+ | [[Exponential survival curve]] | ||
+ | |||
+ | [[Exposure]] | ||
+ | |||
+ | [[Exposure assessment]] | ||
[[Exposure Pathway]] | [[Exposure Pathway]] | ||
[[Exposure situation]] | [[Exposure situation]] | ||
+ | |||
+ | [[External radiation]] | ||
+ | |||
+ | [[Extrapolation number]] | ||
+ | |||
+ | [[Extrathoracic airways]] | ||
+ | |||
+ | [[Extremity dosemeter]] | ||
[[Fairness]] | [[Fairness]] | ||
+ | |||
+ | [[Fault tree analysis]] | ||
+ | |||
+ | [[Field-size effect]] | ||
+ | |||
+ | [[Fixed (surface) contamination]] | ||
+ | |||
+ | [[Flexible tissues]] | ||
+ | |||
+ | [[Fluoroscopically guided interventions]] | ||
+ | |||
+ | [[Forbiddenness]] | ||
+ | |||
+ | [[Fractionation]] | ||
+ | |||
+ | [[Fractionation sensitivity]] | ||
+ | |||
+ | [[Galactic cosmic radiation (GCR)]] | ||
+ | |||
+ | [[Gamma ray]] | ||
+ | |||
+ | [[Gastrointestinal]] | ||
+ | |||
+ | [[Gastrointestinal syndrome]] | ||
+ | |||
+ | [[Geochemical phase association]] | ||
[[Graded approach]] | [[Graded approach]] | ||
+ | |||
+ | [[Granulocyte colony-stimulating factor]] | ||
+ | |||
+ | [[Granulocyte-macrophage colony-stimulating factor]] | ||
+ | |||
+ | [[Growth fraction]] | ||
+ | |||
+ | [[Growth hormone (somatotropin)]] | ||
+ | |||
+ | [[Habitual mouth breather]] | ||
+ | |||
+ | [[Habitual nose breather]] | ||
+ | |||
+ | [[Half-life, physical (T1/2)]] | ||
+ | |||
+ | [[Hazard]] | ||
[[Health Surveillance]] | [[Health Surveillance]] | ||
+ | |||
+ | [[Heliosphere]] | ||
+ | |||
+ | [[Hierarchical tissues]] | ||
+ | |||
+ | [[High level waste, HLW]] | ||
+ | |||
+ | [[Hormones]] | ||
+ | |||
+ | [[Human Respiratory Tract Model (HRTM)]] | ||
+ | |||
+ | [[Hyperbaric oxygen]] | ||
+ | |||
+ | [[Hypertrophic cardiomyopathy]] | ||
+ | |||
+ | [[Hypoplasia]] | ||
+ | |||
+ | [[Immune system]] | ||
+ | |||
+ | [[In vivo measurement]] | ||
+ | |||
+ | [[Inactive (bone) marrow]] | ||
+ | |||
+ | [[Incident]] | ||
[[Inclusiveness]] | [[Inclusiveness]] | ||
+ | |||
+ | [[Individual decontamination]] | ||
+ | |||
+ | [[Individual dose]] | ||
+ | |||
+ | [[Individual dose equivalent]] | ||
[[Individual dose restriction]] | [[Individual dose restriction]] | ||
+ | |||
+ | [[Individual monitoring]] | ||
+ | |||
+ | [[Individual-related]] | ||
+ | |||
+ | [[Individual-related]] | ||
+ | |||
+ | [[Individual-related assessment]] | ||
[[Informed Consent]] | [[Informed Consent]] | ||
+ | |||
+ | [[Ingestion exposure planning zone, IEPZ]] | ||
+ | |||
+ | [[Inhalability]] | ||
+ | |||
+ | [[Inhalation class]] | ||
+ | |||
+ | [[Initial slope]] | ||
+ | |||
+ | [[Inner bremsstrahlung]] | ||
+ | |||
+ | [[Institutional control]] | ||
+ | |||
+ | [[Intermediate level waste, ILW]] | ||
+ | |||
+ | [[Internal conversion electron]] | ||
+ | |||
+ | [[Interphase death]] | ||
+ | |||
+ | [[Intervention Level]] | ||
+ | |||
+ | [[Interventional procedure]] | ||
+ | |||
+ | [[Investigation level]] | ||
+ | |||
+ | [[Iodine prophylaxis]] | ||
+ | |||
+ | [[Iso-effect plots]] | ||
+ | |||
+ | [[Isolation]] | ||
+ | |||
+ | [[Isomeric transition decay]] | ||
+ | |||
+ | [[Isomers]] | ||
+ | |||
+ | [[Isotropic geometry]] | ||
+ | |||
+ | [[Iteroparous]] | ||
+ | |||
+ | [[Itinerant (radiation) worker]] | ||
[[Justice]] | [[Justice]] | ||
+ | |||
+ | [[Justification]] | ||
+ | |||
+ | [[K, Kp index]] | ||
+ | |||
+ | [[Kerma-area product (KAP)]] | ||
+ | |||
+ | [[Late effect, delayed effect]] | ||
+ | |||
+ | [[Latent time/period or latency interval]] | ||
+ | |||
+ | [[Legal person]] | ||
+ | |||
+ | [[Legislators]] | ||
+ | |||
+ | [[Limit]] | ||
+ | |||
+ | [[Limitation of dose]] | ||
+ | |||
+ | [[Lineal energy]] | ||
+ | |||
+ | [[Linear no-threshold (LNT) hypothesis]] | ||
+ | |||
+ | [[Linear-non-threshold (LNT) model]] | ||
+ | |||
+ | [[Low Earth orbit (LEO)]] | ||
+ | |||
+ | [[Low level waste, LLW]] | ||
+ | |||
+ | [[Low toxicity alpha emitter]] | ||
+ | |||
+ | [[Lung absorption type]] | ||
+ | |||
+ | [[Lymphatic system]] | ||
+ | |||
+ | [[Macrophage colony stimulating factor]] | ||
+ | |||
+ | [[Magnetosphere]] | ||
+ | |||
+ | [[Medical exposure]] | ||
+ | |||
+ | [[Medical intervention]] | ||
+ | |||
+ | [[Member of the public]] | ||
+ | |||
+ | [[Mendelian diseases]] | ||
+ | |||
+ | [[Minimum significant activity (MSA)]] | ||
+ | |||
+ | [[Mitigation]] | ||
+ | |||
+ | [[Monitoring]] | ||
+ | |||
+ | [[Multistage tumorigenesis]] | ||
+ | |||
+ | [[Myocardial perfusion]] | ||
+ | |||
+ | [[Nasal Augmenter]] | ||
+ | |||
+ | [[Natural background]] | ||
+ | |||
+ | [[Natural environment]] | ||
+ | |||
+ | [[Naturally occurring radioactive material (NORM)]] | ||
+ | |||
+ | [[Necrosis]] | ||
+ | |||
+ | [[Neurological syndrome]] | ||
+ | |||
+ | [[Neurovascular syndrome]] | ||
[[Non-maleficence]] | [[Non-maleficence]] |
Revision as of 18:43, 8 April 2019
Activity median thermodynamic diameter (AMTD)
Alimentary tract transfer factor, fA
Alveolar-interstitial region, AI
Best Available Techniques (BAT)
Category of exposed individual
Committed effective dose, E(τ)
Computed tomography dose index, CTDI
Conditional renewing (complex or flexible) tissues
Coronary heart disease/congestive heart disease
Derived consideration reference level
Dose equivalent in an organ or tissue, HT,Q
Dose rate effectiveness factor, DREF
Environmental (radiation) monitoring
Environmental radiation protection
Fluoroscopically guided interventions
Galactic cosmic radiation (GCR)
Granulocyte colony-stimulating factor
Granulocyte-macrophage colony-stimulating factor
Human Respiratory Tract Model (HRTM)
Ingestion exposure planning zone, IEPZ
Latent time/period or latency interval
Linear no-threshold (LNT) hypothesis
Linear-non-threshold (LNT) model
Macrophage colony stimulating factor
Minimum significant activity (MSA)
Naturally occurring radioactive material (NORM)
Practical radiological protection culture
Principle of application of dose limits
Rehabilitation of living conditions